This message was sent to ##Email##
|
|
|
|
|
SCAI
SCAI members Joseph Babb, MD, MSCAI (SCAI Past-President), Arthur C. Lee, MD, FSCAI, Osvaldo Gigliotti, MD, FSCAI, (SCAI Advocacy Committee Chair) and K.C. Kurian, MD, FSCAI, represented the Society this week at the Alliance of Specialty Medicine Advocacy Conference. They were on hand to participate in multiple visits with Congressional leaders and staff to advocate for sound federal healthcare policies that foster patient access to quality medical care.
Learn more about their trip to Capitol Hill in the upcoming issue of SCAI News & Highlights!
SCAI
Investigators leading the Mitral Annular Calcification (MAC) Global Registry examining the use of transcatheter mitral valve replacement via balloon-expandable valves designed for aortic stenosis have, for the first time, published the outcomes of the earliest-treated patients in a peer-reviewed journal. In a separate publication in Catheterization and Cardiovascular Interventions, Guerrero and colleagues describe the use of percutaneous alcohol septal ablation to acutely reduce LVOT obstruction induced by transcatheter mitral valve replacement.
Read more
SCAI
The testimony details concerns regarding the proposals in the CMS proposed rule titled "Medicare Program; Merit-Based Incentive Payment System (MIPS) and Alternative Payment Model (APM) Incentive under the Physician Fee Schedule, and Criteria for Physician-Focused Payment Models."
Read the full testimony here
SCAI
SCAI and 46 medical organizations submitted a letter this week to the House Appropriations Committee in opposition to the $110 million funding cut in the House FY 2017 Labor, Health and Human Services, Education, and Related Agencies Appropriations bill for the Centers for Disease Control and Prevention's (CDC) Office on Smoking and Health (OSH). The letter urges the Committee to restore this funding and allocate at least $210 million to OSH, which is the amount Congress enacted for FY 2016. The work that OSH does is critical to ending the tobacco epidemic that takes far too many lives and exacts an enormous financial toll on the nation's economy.
Read the full letter here
TCTMD
Many medications can worsen heart failure in patients who have the condition already or even cause new cases. But much can be done to address the potential for toxicity or drug-drug interactions, according to a scientific statement released by the American Heart Association that gathers together existing evidence on the issue.
READ MORE
The Cardiology Advisor
After experiencing their first myocardial infarction (MI), patients who later developed heart failure had an increased risk of cancer, according to research published in the Journal of the American College of Cardiology. Tal Hasin, MD, of the Department of Cardiology at the Shaare Zedek Medical Center in Jerusalem, and colleagues evaluated the association between heart failure and risk of cancer among MI survivors.
READ MORE
|
Promoted by
|
|
|
|
 |
MedPage Today
The Food and Drug Administration has approved a device that can deliver a single monthly injection of evolocumab (Repatha), the cholesterol-lowering PCSK9 inhibitor manufactured by Amgen. Repatha is currently administered by subcutaneous injection in a 140-milligram dose every two weeks or as a 420 milligram monthly dose.
READ MORE
 |
|
Now available with a nitinol wire, meeting preferences for a more durable wire and more tactile feel. Included is a stainless steel needle for single wall, micropuncture technique. Adding to SS and A-Kit options, Terumo now offers a full family of thin wall, introducer sheath kits for additional procedural preferences.
©2016 Terumo Medical Corporation. All rights reserved.
All brand names are trademarks or registered trademarks of Terumo. TIS-310-05242016
|
|
Medscape
Stopping and restarting oral anti-coagulation therapy and then starting and stopping parenteral "bridging anti-coagulation" for patients who need surgery or other invasive procedures are complex processes that need specific institutional protocols and coordination between several specialties, suggests new research. An American College of Cardiology-approved online survey was created to assess current practice patterns for patients needing to interrupt their anti-coagulation therapy.
READ MORE
Healio
Within one week of left atrial appendage closure with an Amplatzer device, the rate of early procedural success was high and major adverse events were low. Predictors of early safety events included device repositioning and depressed left ventricular ejection fraction, researchers reported in JACC: Cardiovascular Interventions.
READ MORE
 |
|
PrognoCIS Electronic Health Record (EHR) and services use the latest internet technologies to provide efficient practice management and medical billing, meeting the needs of Cardiologists around the country.
Learn why our members say we’re “More Than a Great EHR.”
|
|
Cardiovascular Business
A significant advancement was made in cardiovascular care for patients suffering from heart problems.
A new dissolvable heart stent was approved July 5 by the Food and Drug Administration and was implanted into a patient the very next day at HonorHealth in Scottsdale, Arizona.
READ MORE
Pulsara
Repeating the ECG after you've already received one from the medics wastes precious time and tissue. Rethinking that protocol could mean improved outcomes for your patients.
READ MORE
Medscape
Debaters at the Society of Cardiovascular Computed Tomography 2016 Annual Scientific Meeting agreed that an initial computed tomography test is best to rule out coronary artery disease in low-risk patients but squared off over whether this strategy is best for intermediate-risk patients.
Recent studies show that "coronary computed tomography angiography should be the first diagnostic test for coronary artery disease," said Dr. Todd C. Villines, arguing for the "pro" side in the debate.
READ MORE
|
Missed last week's issue? See which articles your colleagues read most.
|
|
Don't be left behind. Click here to see what else you missed.
|
| Date |
Event |
Location |
| July 28- 29 |
Complex Interventional Cardiovascular Therapy (CICT) 2016 |
San Francisco, CA
|
| Aug. 20-21 |
SCAI-NCDD China Fellows Course
|
Shijiazhuang, CHINA
|
| Aug. 25-28 |
ACC/SCAI Premier Interventional Cardiology Overview and Board Preparatory Course Gold Package
|
Amelia Island, FL
|
| Sept. 30-Oct. 1 |
3rd Annual Chicago CSI: Case Based Coronary and Structural Heart Intervention Update |
Chicago, IL
|
| Oct. 1 |
TRIP-VASC |
Chicago, IL
|
| Dec. 10-14 |
SCAI 2016 Fall Fellows Courses |
Las Vegas, NV
|
| May 10-13, 2017 |
SCAI 2017 Scientific Sessions |
New Orleans, LA
|
| Dec. 9-12, 2017 |
SCAI 2017 Fall Fellows Courses |
Las Vegas, NV
|
For a complete list of job postings, click here.
To post your resume, click here.
|
|
|
|
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
